HEALTHSTORY 767· JULY 1, 2026

Anthropic Enters Drug Development With Claude Science Launch; Trump Drug Pricing Plan Faces Mid-Size Pharma Test

Anthropic has released Claude Science, a version of its large language model configured specifically for scientific laboratories and pharmaceutical research operations, becoming the first large artif

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 766Avista Healthcare Partners Closes Acquisition of Sanotact Group GmbH NEXT STORY 768 →Mobility Global Inc. Launches as Independent NYSE-Listed Automotive Data Company After S&P Global Separation

Keep reading

More from the desk.

02HEALTH

Alnylam defends its heart drugs after AstraZeneca's Wainua trial fails

A treatment for ATTR-CM, a heart condition, failed its clinical trial on Friday, and the fallout reached beyond the company that ran the test. AstraZeneca disclosed that its drug Wainua did not

health1 MIN

07HEALTH

FDA clears Mimrylo for rare blood cancer that thickens patients' blood

A new weekly injection for polycythemia vera, a rare chronic blood cancer that causes the body to overproduce red blood cells and thicken the blood, won Food and Drug Administration approval on Friday. The drug is called rusfertide…

health2 MIN

12HEALTH

Novartis drug pacibekitug cuts inflammation markers in midstage heart study

A drug designed to interrupt a specific inflammation signal in the body reduced measurable signs of that inflammation in a midstage clinical trial. Biomarkers, the proteins used to track whether inflammation is active inside a patient…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk